Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...
Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback